PortfoliosLab logo
BLFS vs. AVGO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BLFS and AVGO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

BLFS vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BLFS:

0.01

AVGO:

1.27

Sortino Ratio

BLFS:

0.39

AVGO:

1.91

Omega Ratio

BLFS:

1.05

AVGO:

1.25

Calmar Ratio

BLFS:

-0.01

AVGO:

1.79

Martin Ratio

BLFS:

-0.10

AVGO:

4.93

Ulcer Index

BLFS:

11.04%

AVGO:

14.92%

Daily Std Dev

BLFS:

56.97%

AVGO:

63.11%

Max Drawdown

BLFS:

-99.98%

AVGO:

-48.30%

Current Drawdown

BLFS:

-98.41%

AVGO:

-2.62%

Fundamentals

Market Cap

BLFS:

$1.04B

AVGO:

$1.14T

EPS

BLFS:

-$0.19

AVGO:

$2.15

PEG Ratio

BLFS:

65.38

AVGO:

0.64

PS Ratio

BLFS:

11.86

AVGO:

20.87

PB Ratio

BLFS:

2.95

AVGO:

16.30

Total Revenue (TTM)

BLFS:

$79.42M

AVGO:

$42.04B

Gross Profit (TTM)

BLFS:

$60.76M

AVGO:

$27.50B

EBITDA (TTM)

BLFS:

$3.39M

AVGO:

$19.89B

Returns By Period

In the year-to-date period, BLFS achieves a -15.72% return, which is significantly lower than AVGO's 4.73% return. Over the past 10 years, BLFS has underperformed AVGO with an annualized return of 27.16%, while AVGO has yielded a comparatively higher 36.05% annualized return.


BLFS

YTD

-15.72%

1M

-11.06%

6M

-20.35%

1Y

1.86%

3Y*

16.83%

5Y*

5.87%

10Y*

27.16%

AVGO

YTD

4.73%

1M

22.67%

6M

50.21%

1Y

84.43%

3Y*

64.45%

5Y*

56.68%

10Y*

36.05%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BioLife Solutions, Inc.

Broadcom Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

BLFS vs. AVGO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLFS
The Risk-Adjusted Performance Rank of BLFS is 4848
Overall Rank
The Sharpe Ratio Rank of BLFS is 5050
Sharpe Ratio Rank
The Sortino Ratio Rank of BLFS is 4747
Sortino Ratio Rank
The Omega Ratio Rank of BLFS is 4646
Omega Ratio Rank
The Calmar Ratio Rank of BLFS is 5050
Calmar Ratio Rank
The Martin Ratio Rank of BLFS is 4848
Martin Ratio Rank

AVGO
The Risk-Adjusted Performance Rank of AVGO is 8686
Overall Rank
The Sharpe Ratio Rank of AVGO is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of AVGO is 8484
Sortino Ratio Rank
The Omega Ratio Rank of AVGO is 8383
Omega Ratio Rank
The Calmar Ratio Rank of AVGO is 9191
Calmar Ratio Rank
The Martin Ratio Rank of AVGO is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BLFS vs. AVGO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BLFS Sharpe Ratio is 0.01, which is lower than the AVGO Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of BLFS and AVGO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

BLFS vs. AVGO - Dividend Comparison

BLFS has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.92%.


TTM20242023202220212020201920182017201620152014
BLFS
BioLife Solutions, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
0.92%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%1.22%

Drawdowns

BLFS vs. AVGO - Drawdown Comparison

The maximum BLFS drawdown since its inception was -99.98%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for BLFS and AVGO.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

BLFS vs. AVGO - Volatility Comparison

BioLife Solutions, Inc. (BLFS) has a higher volatility of 17.31% compared to Broadcom Inc. (AVGO) at 9.20%. This indicates that BLFS's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BLFS vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between BioLife Solutions, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
23.94M
14.92B
(BLFS) Total Revenue
(AVGO) Total Revenue
Values in USD except per share items

BLFS vs. AVGO - Profitability Comparison

The chart below illustrates the profitability comparison between BioLife Solutions, Inc. and Broadcom Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20212022202320242025
65.9%
68.0%
(BLFS) Gross Margin
(AVGO) Gross Margin
BLFS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, BioLife Solutions, Inc. reported a gross profit of 15.79M and revenue of 23.94M. Therefore, the gross margin over that period was 65.9%.

AVGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Broadcom Inc. reported a gross profit of 10.15B and revenue of 14.92B. Therefore, the gross margin over that period was 68.0%.

BLFS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, BioLife Solutions, Inc. reported an operating income of -1.22M and revenue of 23.94M, resulting in an operating margin of -5.1%.

AVGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Broadcom Inc. reported an operating income of 6.26B and revenue of 14.92B, resulting in an operating margin of 42.0%.

BLFS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, BioLife Solutions, Inc. reported a net income of -448.00K and revenue of 23.94M, resulting in a net margin of -1.9%.

AVGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Broadcom Inc. reported a net income of 5.50B and revenue of 14.92B, resulting in a net margin of 36.9%.